Cargando…
Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
Purpose: The optimal cumulative dose of radioactive iodine therapy (RAIT) for patients with differentiated thyroid cancer (DTC) and pulmonary metastases (PM) is not known, therefore we evaluated the association between the cumulative dose of RAIT and overall survival (OS). Methods: A total of 202 pa...
Autores principales: | Yang, Jing, Zheng, Rong, Liang, Meng, Jia, Yingying, Lin, Lin, Geng, Jianhua, Chen, Shengzu, Li, Ye-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609903/ https://www.ncbi.nlm.nih.gov/pubmed/31316914 http://dx.doi.org/10.3389/fonc.2019.00558 |
Ejemplares similares
-
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
por: Jannin, Arnaud, et al.
Publicado: (2022) -
Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy
por: Yang, Jing, et al.
Publicado: (2017) -
Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)
por: Yang, Qiong, et al.
Publicado: (2019) -
Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions
por: Wei, Shuhua, et al.
Publicado: (2021) -
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)